Primary percutaneous coronary intervention for acute MI: improving access and outcomes

Juhana Karha; Matthew A Hook; Sorin J Brener

doi:10.3949/ccjm.72.7.559

Primary percutaneous coronary intervention for acute MI: improving access and outcomes

Cleve Clin J Med. 2005 Jul;72(7):559-60, 562, 565-6 passim. doi: 10.3949/ccjm.72.7.559.

Authors

Juhana Karha¹, Matthew A Hook, Sorin J Brener

Affiliation

¹ Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, OH 44195, USA.

PMID: 16044653
DOI: 10.3949/ccjm.72.7.559

Abstract

Patients with acute myocardial infarction (MI) with ST-segment elevation have better outcomes with primary percutaneous coronary intervention (PCI) than with fibrinolytic therapy. Multiple clinical trials in the past 10 years have addressed ways to improve PCI as primary therapy for acute MI. Logistic strategies to improve access to PCI are being studied.

Publication types

Review

MeSH terms

Abciximab
Angioplasty, Balloon, Coronary*
Antibodies, Monoclonal / therapeutic use
Electrocardiography
Humans
Immunoglobulin Fab Fragments / therapeutic use
Myocardial Infarction / therapy*
Platelet Aggregation Inhibitors / therapeutic use
Stents

Substances

Antibodies, Monoclonal
Immunoglobulin Fab Fragments
Platelet Aggregation Inhibitors
Abciximab